|
The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. Non-Invasive Monitoring Systems announces $50K promissory noteSterionics and Biolectrics land LCCC Innovation Fund grantsLORAIN COUNTY COMMUNITY COLLEGE FOUNDATION’S INNOVATION FUND ANNOUNCES LATEST ROUND OF INVESTMENTS The Innovation Fund, administered by the Lorain County Community College Foundation, is investing $350,000 in five technology start-up companies in the latest round of awards announced this past August. Funds from Ohio’s Third Frontier Program combined with matching local support and contributions from a variety of partners are used to make the Innovation Fund awards. Teladoc lands $18.6 million funding roundTeladoc announced this week a round of funding totaling $18.6 million, led by Kleiner Perkins Caufield & Byers (KPCB). Other investors in the funding round include Cardinal Partners, HLM Venture Partners, Trident Capital, and New Capital Partners. HealthTech Capital doles out $800,000 to two companiesHealthTech Capital Announces Two New Investments in the Emerging HealthTech Market UMass Amherst lands $20 million federal grantUMass Amherst Nanotechnology Center Receives $20 Million Renewal of Federal Grant to Boost Advanced Manufacturing, Economic Growth
AMHERST, Mass. – The University of Massachusetts Amherst has received a five-year, $20 million grant from the National Science Foundation (NSF) to support a national research center on nanomanufacturing. The grant will fund the university’s Center for Hierarchical Manufacturing (CHM). Fresenius notes offering get Ba2 rating from Moody’sMoody’s assigns Ba2 rating to $960M in Fresenius notesBoston Business Journal by Julie M. Donnelly , juliedonnelly@bizjournals.comDate: Wednesday, September 14, 2011, 3:38pm EDT Moody’s Investors Service has assigned a definite Ba2 rating to about $960 million in bonds issued by finance companies wholly owned by Fresenius Medical Care AG & Co. KGaA (NYSE: FMS), a Germany-based global provider of dialysis services. The company’s North American operations are headquartered in Waltham, Mass. Surgimatrix hopes for $500,000 equity round
|
